These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 28733028)

  • 1. Bifidobacterium longum affects the methylation level of forkhead box P3 promoter in 2, 4, 6-trinitrobenzenesulphonic acid induced colitis in rats.
    Zhang M; Zhou L; Zhang S; Yang Y; Xu L; Hua Z; Zou X
    Microb Pathog; 2017 Sep; 110():426-430. PubMed ID: 28733028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Faecalibacterium prausnitzii upregulates regulatory T cells and anti-inflammatory cytokines in treating TNBS-induced colitis.
    Qiu X; Zhang M; Yang X; Hong N; Yu C
    J Crohns Colitis; 2013 Dec; 7(11):e558-68. PubMed ID: 23643066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bifidobacterium longum and VSL#3
    Chen X; Fu Y; Wang L; Qian W; Zheng F; Hou X
    Dev Comp Immunol; 2019 Mar; 92():77-86. PubMed ID: 30227219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Both viable
    Li Z; Peng C; Sun Y; Zhang T; Feng C; Zhang W; Huang T; Yao G; Zhang H; He Q
    Microbiol Spectr; 2024 Jun; 12(6):e0350923. PubMed ID: 38647334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of TNBS-induced colitis by different Lactobacillus and Bifidobacterium strains is associated with an expansion of gammadeltaT and regulatory T cells of intestinal intraepithelial lymphocytes.
    Roselli M; Finamore A; Nuccitelli S; Carnevali P; Brigidi P; Vitali B; Nobili F; Rami R; Garaguso I; Mengheri E
    Inflamm Bowel Dis; 2009 Oct; 15(10):1526-36. PubMed ID: 19504616
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Zhou L; Liu D; Xie Y; Yao X; Li Y
    Gut Liver; 2019 Mar; 13(4):430-439. PubMed ID: 30600673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bifidobacterium infantis attenuates colitis by regulating T cell subset responses.
    Zuo L; Yuan KT; Yu L; Meng QH; Chung PC; Yang DH
    World J Gastroenterol; 2014 Dec; 20(48):18316-29. PubMed ID: 25561798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active hexose-correlated compound and Bifidobacterium longum BB536 exert symbiotic effects in experimental colitis.
    Ocón B; Anzola A; Ortega-González M; Zarzuelo A; Suárez MD; Sánchez de Medina F; Martínez-Augustin O
    Eur J Nutr; 2013 Mar; 52(2):457-66. PubMed ID: 22941198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-inflammatory potential of the probiotic dietary supplement Lactibiane Tolérance: in vitro and in vivo considerations.
    Drouault-Holowacz S; Foligné B; Dennin V; Goudercourt D; Terpend K; Burckel A; Pot B
    Clin Nutr; 2006 Dec; 25(6):994-1003. PubMed ID: 16698150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treg-inducing capacity of genomic DNA of
    Li D; Cheng J; Zhu Z; Catalfamo M; Goerlitz D; Lawless OJ; Tallon L; Sadzewicz L; Calderone R; Bellanti JA
    Allergy Asthma Proc; 2020 Sep; 41(5):372-385. PubMed ID: 32867892
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic effects of mucosal tolerance on experimental colitis in rats.
    Shan-Shan Z; Yu-Lan L
    Eur J Gastroenterol Hepatol; 2009 Oct; 21(10):1145-52. PubMed ID: 19478680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of CD4+ forkhead box P3 (FOXP3)+ regulatory T cells in inflammatory bowel disease.
    Wang Y; Liu XP; Zhao ZB; Chen JH; Yu CG
    J Dig Dis; 2011 Aug; 12(4):286-94. PubMed ID: 21791023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Probiotic therapy using live combined bifidobacterium, lactobacillus and enterococcus for experimental colitis in rats model].
    Wan YM; Zhu YQ; Xia B; Luo J
    Zhonghua Nei Ke Za Zhi; 2010 May; 49(5):418-21. PubMed ID: 20646418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with
    Abrantes FA; Nascimento BB; Andrade MER; de Barros PAV; Cartelle CT; Martins FS; Nicoli JR; Arantes RME; Generoso SV; Fernandes SOA; Cardoso VN
    Benef Microbes; 2020 Feb; 11(1):47-57. PubMed ID: 32066260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with Bifidobacterium bifidum 17 partially protects mice from Th1-driven inflammation in a chemically induced model of colitis.
    Philippe D; Heupel E; Blum-Sperisen S; Riedel CU
    Int J Food Microbiol; 2011 Sep; 149(1):45-9. PubMed ID: 21257218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovery from TNBS-induced colitis leads to the resistance to recurrent colitis and an increased ratio of FOXP3 to CD3 mRNA.
    Chen DF; Lu LG; Tao KZ; Lu ZJ; Yuan YZ
    J Dig Dis; 2013 Nov; 14(11):587-95. PubMed ID: 23786412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressor of cytokine signaling-1 ameliorates dextran sulfate sodium-induced colitis in mice.
    Horino J; Fujimoto M; Terabe F; Serada S; Takahashi T; Soma Y; Tanaka K; Chinen T; Yoshimura A; Nomura S; Kawase I; Hayashi N; Kishimoto T; Naka T
    Int Immunol; 2008 Jun; 20(6):753-62. PubMed ID: 18381351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous Amelioratation of Colitis and Liver Injury in Mice by Bifidobacterium longum LC67 and Lactobacillus plantarum LC27.
    Jang SE; Jeong JJ; Kim JK; Han MJ; Kim DH
    Sci Rep; 2018 May; 8(1):7500. PubMed ID: 29760423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study on the interactions between transplanted bone marrow-derived mesenchymal stem cells and regulatory T cells for the treatment of experimental colitis.
    Zuo D; Liu X; Shou Z; Fan H; Tang Q; Duan X; Cao D; Zou Z; Zhang L
    Int J Mol Med; 2013 Dec; 32(6):1337-44. PubMed ID: 24142133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bifidobacteria alleviate experimentally induced colitis by upregulating indoleamine 2, 3-dioxygenase expression.
    Zhao L; Suolang Y; Zhou D; Tang Y; Zhang Y
    Microbiol Immunol; 2018 Feb; 62(2):71-79. PubMed ID: 29226383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.